Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $FEMY vs $NMTC | Chartloom

Compare

$FEMY vs $NMTC

Femasys Inc · NeuroOne Medical Technologies Corp

FEMY

Femasys Inc

NMTC

NeuroOne Medical Technologies Corp

Compare $FEMY vs $NMTC

Comparing Femasys Inc and NeuroOne Medical Technologies Corp

FEMYFemasys Inc

NMTCNeuroOne Medical Technologies Corp

FEMYFemasys Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.95x

Rev growth (TTM)

21.9%

YTD performance

-86.2%

52W performance

-85.6%

FCF yield

-342.2%

NMTCNeuroOne Medical Technologies Corp

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.76x

Rev growth (TTM)

3.8%

YTD performance

-78.5%

52W performance

-80.7%

FCF yield

-74.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FEMY

NMTC

Detailed metrics comparison

FEMY

Femasys Inc

NMTC

NeuroOne Medical Technologies Corp

Market Cap

FEMY$5M

NMTC$10M

Enterprise Value

FEMY$7M

NMTC$8M

Price

FEMY$1.76

NMTC$1.10

P/E Ratio

FEMYN/A

NMTCN/A

P/S Ratio

FEMY2.31x

NMTC0.96x

EV/Sales

FEMY3.22x

NMTC0.75x

EV/EBITDA

FEMY0.00x

NMTC0.00x

P/B Ratio

FEMY4.16x

NMTC2.71x

P/FCF Ratio

FEMYN/A

NMTCN/A

EV/FCF

FEMY-0.41x

NMTC-1.05x

PEG Ratio

FEMYN/A

NMTCN/A

Forward P/E (NTM)

FEMYN/A

NMTCN/A

Forward P/S (NTM)

FEMY0.95x

NMTC0.76x

Revenue (TTM)

FEMY$2M

NMTC$10M

Revenue Growth (YoY)

FEMY21.9%

NMTC3.8%

Forward Rev Growth

FEMY297.9%

NMTC57.3%

Gross Margin (TTM)

FEMY61.0%

NMTC55.7%

Operating Margin (TTM)

FEMY0.0%

NMTC0.0%

EBITDA Margin (TTM)

FEMY-749.3%

NMTC-73.7%

Net Margin (TTM)

FEMY-511.8%

NMTC-71.5%

FCF Margin (TTM)

FEMY-791.0%

NMTC-71.6%

Net Income (TTM)

FEMY$-12M

NMTC$-7M

FCF (TTM)

FEMY$-18M

NMTC$-7M

EPS (TTM)

FEMY-$3.51

NMTC-$0.83

ROE (TTM)

FEMY-21646.0%

NMTC-12645.0%

ROA (TTM)

FEMY-7154.0%

NMTC-8558.0%

ROIC (TTM)

FEMY-12206.0%

NMTC-12645.0%

Cash

FEMY$1M

NMTC$2M

Debt

FEMY$4M

NMTC$0

Net Cash/Debt

FEMY$-2M

NMTC$2M

Current Ratio (TTM)

FEMY2.14x

NMTC2.84x

Quick Ratio (TTM)

FEMY0.55x

NMTC1.56x

Debt/Equity (TTM)

FEMY0.87x

NMTC0.00x

Debt/Assets (TTM)

FEMY0.0%

NMTC0.0%

Interest Coverage (TTM)

FEMYN/A

NMTCN/A

Net Debt/EBITDA (TTM)

FEMY0.00x

NMTC0.00x

Beta

FEMY-2.33

NMTC0.92

52W Performance

FEMY-85.6%

NMTC-80.7%

YTD Performance

FEMY-86.2%

NMTC-78.5%

% from 52W High

FEMY-92.1%

NMTC-82.0%

% from 52W Low

FEMY5.4%

NMTC14.4%

Asset Turnover (TTM)

FEMY0.14x

NMTC1.20x

FCF Yield (TTM)

FEMY-342.2%

NMTC-74.8%

Earnings Yield (TTM)

FEMY-221.4%

NMTC-74.7%

Dividend Yield (TTM)

FEMYN/A

NMTCN/A

Rule of 40

FEMY-769.2

NMTC-67.8

EV/GP/RG

FEMY0.04

NMTC0.05

Ticker research

View FEMY research View NMTC research

Metric	FEMY Femasys Inc	NMTC NeuroOne Medical Technologies Corp
Market & Valuation
Market Cap	$5M	$10M
Enterprise Value	$7M	$8M
Price	$1.76	$1.10
P/E Ratio	N/A	N/A
P/S Ratio	2.31x	0.96x
EV/Sales	3.22x	0.75x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.16x	2.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.41x	-1.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	0.95x	0.76x
Revenue & Growth
Revenue (TTM)	$2M	$10M
Revenue Growth (YoY)	21.9%	3.8%
Forward Rev Growth	297.9%	57.3%
Profitability
Gross Margin (TTM)	61.0%	55.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-749.3%	-73.7%
Net Margin (TTM)	-511.8%	-71.5%
FCF Margin (TTM)	-791.0%	-71.6%
Net Income (TTM)	$-12M	$-7M
FCF (TTM)	$-18M	$-7M
EPS (TTM)	-$3.51	-$0.83
ROE (TTM)	-21646.0%	-12645.0%
ROA (TTM)	-7154.0%	-8558.0%
ROIC (TTM)	-12206.0%	-12645.0%
Financial Health
Cash	$1M	$2M
Debt	$4M	$0
Net Cash/Debt	$-2M	$2M
Current Ratio (TTM)	2.14x	2.84x
Quick Ratio (TTM)	0.55x	1.56x
Debt/Equity (TTM)	0.87x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.33	0.92
52W Performance	-85.6%	-80.7%
YTD Performance	-86.2%	-78.5%
% from 52W High	-92.1%	-82.0%
% from 52W Low	5.4%	14.4%
Efficiency & Yields
Asset Turnover (TTM)	0.14x	1.20x
FCF Yield (TTM)	-342.2%	-74.8%
Earnings Yield (TTM)	-221.4%	-74.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-769.2	-67.8
EV/GP/RG	0.04	0.05
Ticker research	View FEMY research	View NMTC research

Valuation

P/S Ratio

NMTC

0.96x

FEMY

2.31x

EV/FCF

NMTC

-1.05x

FEMY

-0.41x

Growth & revenue

Revenue Growth TTM

FEMY

21.9%

NMTC

3.8%

Forward Revenue Growth

FEMY

297.9%

NMTC

57.3%

Profitability & performance

Gross Margin

FEMY

61.0%

NMTC

55.7%

ROE

NMTC

-12645.0%

FEMY

-21646.0%

FCF Yield %

NMTC

-74.8%

FEMY

-342.2%

52-Week Performance

NMTC

-80.7%

FEMY

-85.6%

Detailed metrics comparison

FEMY

Femasys Inc

NMTC

NeuroOne Medical Technologies Corp

Market Cap

FEMY$5M

NMTC$10M

Enterprise Value

FEMY$7M

NMTC$8M

Price

FEMY$1.76

NMTC$1.10

P/E Ratio

FEMYN/A

NMTCN/A

P/S Ratio

FEMY2.31x

NMTC0.96x

EV/Sales

FEMY3.22x

NMTC0.75x

EV/EBITDA

FEMY0.00x

NMTC0.00x

P/B Ratio

FEMY4.16x

NMTC2.71x

P/FCF Ratio

FEMYN/A

NMTCN/A

EV/FCF

FEMY-0.41x

NMTC-1.05x

PEG Ratio

FEMYN/A

NMTCN/A

Forward P/E (NTM)

FEMYN/A

NMTCN/A

Forward P/S (NTM)

FEMY0.95x

NMTC0.76x

Revenue (TTM)

FEMY$2M

NMTC$10M

Revenue Growth (YoY)

FEMY21.9%

NMTC3.8%

Forward Rev Growth

FEMY297.9%

NMTC57.3%

Gross Margin (TTM)

FEMY61.0%

NMTC55.7%

Operating Margin (TTM)

FEMY0.0%

NMTC0.0%

EBITDA Margin (TTM)

FEMY-749.3%

NMTC-73.7%

Net Margin (TTM)

FEMY-511.8%

NMTC-71.5%

FCF Margin (TTM)

FEMY-791.0%

NMTC-71.6%

Net Income (TTM)

FEMY$-12M

NMTC$-7M

FCF (TTM)

FEMY$-18M

NMTC$-7M

EPS (TTM)

FEMY-$3.51

NMTC-$0.83

ROE (TTM)

FEMY-21646.0%

NMTC-12645.0%

ROA (TTM)

FEMY-7154.0%

NMTC-8558.0%

ROIC (TTM)

FEMY-12206.0%

NMTC-12645.0%

Cash

FEMY$1M

NMTC$2M

Debt

FEMY$4M

NMTC$0

Net Cash/Debt

FEMY$-2M

NMTC$2M

Current Ratio (TTM)

FEMY2.14x

NMTC2.84x

Quick Ratio (TTM)

FEMY0.55x

NMTC1.56x

Debt/Equity (TTM)

FEMY0.87x

NMTC0.00x

Debt/Assets (TTM)

FEMY0.0%

NMTC0.0%

Interest Coverage (TTM)

FEMYN/A

NMTCN/A

Net Debt/EBITDA (TTM)

FEMY0.00x

NMTC0.00x

Beta

FEMY-2.33

NMTC0.92

52W Performance

FEMY-85.6%

NMTC-80.7%

YTD Performance

FEMY-86.2%

NMTC-78.5%

% from 52W High

FEMY-92.1%

NMTC-82.0%

% from 52W Low

FEMY5.4%

NMTC14.4%

Asset Turnover (TTM)

FEMY0.14x

NMTC1.20x

FCF Yield (TTM)

FEMY-342.2%

NMTC-74.8%

Earnings Yield (TTM)

FEMY-221.4%

NMTC-74.7%

Dividend Yield (TTM)

FEMYN/A

NMTCN/A

Rule of 40

FEMY-769.2

NMTC-67.8

EV/GP/RG

FEMY0.04

NMTC0.05

Ticker research

View FEMY research View NMTC research

Metric	FEMY Femasys Inc	NMTC NeuroOne Medical Technologies Corp
Market & Valuation
Market Cap	$5M	$10M
Enterprise Value	$7M	$8M
Price	$1.76	$1.10
P/E Ratio	N/A	N/A
P/S Ratio	2.31x	0.96x
EV/Sales	3.22x	0.75x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.16x	2.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.41x	-1.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	0.95x	0.76x
Revenue & Growth
Revenue (TTM)	$2M	$10M
Revenue Growth (YoY)	21.9%	3.8%
Forward Rev Growth	297.9%	57.3%
Profitability
Gross Margin (TTM)	61.0%	55.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-749.3%	-73.7%
Net Margin (TTM)	-511.8%	-71.5%
FCF Margin (TTM)	-791.0%	-71.6%
Net Income (TTM)	$-12M	$-7M
FCF (TTM)	$-18M	$-7M
EPS (TTM)	-$3.51	-$0.83
ROE (TTM)	-21646.0%	-12645.0%
ROA (TTM)	-7154.0%	-8558.0%
ROIC (TTM)	-12206.0%	-12645.0%
Financial Health
Cash	$1M	$2M
Debt	$4M	$0
Net Cash/Debt	$-2M	$2M
Current Ratio (TTM)	2.14x	2.84x
Quick Ratio (TTM)	0.55x	1.56x
Debt/Equity (TTM)	0.87x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.33	0.92
52W Performance	-85.6%	-80.7%
YTD Performance	-86.2%	-78.5%
% from 52W High	-92.1%	-82.0%
% from 52W Low	5.4%	14.4%
Efficiency & Yields
Asset Turnover (TTM)	0.14x	1.20x
FCF Yield (TTM)	-342.2%	-74.8%
Earnings Yield (TTM)	-221.4%	-74.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-769.2	-67.8
EV/GP/RG	0.04	0.05
Ticker research	View FEMY research	View NMTC research